Friday, June 24, 2016 1:13:51 PM
IT WAS A PHYSICALLY IMPOSSIBLE TIMELINE that Seymour and Diwan told investors to rely upon, that was contrary to the information the FDA makes publicly available.
It is physically impossible to complete everything required for FDA approval of *ANY* drug within years of Seymour's and Diwan's timelines.
Seymour and Diwan just made up those impossible timelines to trick investors into investing in NNVC based on their lies.
No drug in the history of the FDA has ever been approved within years of what Seymour and Diwan were telling investors.
That's because IT IS PHYSICALLY IMPOSSIBLE to complete all of the requirements for FDA approval of *ANY* drug within those timelines.
The fact that Seymour and Diwan were willfully defrauding the investing public with fictional and impossible timelines is clearly supported by the data the FDA has made publicly available ever since they've had a public website:
http://www.fdareview.org/03_drug_development.php
Seymour and Diwan decided to misinform investors about the minimum amount of time it takes to develop *any* drug, and about the risks in doing so. And not just by a little bit.
When Seymour and Diwan made that choice, they clearly crossed the line. And then they made themselves multimillionaires by doing so, at the expense of NNVC investors.
No ifs, ands, or buts about it.
A casual stroll through the lunatic asylum shows that faith does not prove anything. Friedrich Nietzsche
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM